Anzeige
Mehr »
Lynx Broker
Login
Samstag, 19.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M84G ISIN: SE0002190926 Ticker-Symbol: 2I9 
Frankfurt
18.10.19
08:02 Uhr
0,319 Euro
+0,019
+6,33 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
KAROLINSKA DEVELOPMENT AB Chart 1 Jahr
5-Tage-Chart
KAROLINSKA DEVELOPMENT AB 5-Tage-Chart

Aktuelle News zur KAROLINSKA DEVELOPMENT Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
KAROLINSKA DEVELOPMENT Aktien jetzt im kostenlosen Demokonto handeln!
MoKarolinska Development AB (publ): Karolinska Development's portfolio company OssDsign receives US FDA clearance for Cranial PSI Accessories125STOCKHOLM, SWEDEN - October 14, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company, OssDsign AB, has been granted 510(k) clearance by the US Food and Drug...
► Artikel lesen
08.10.Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics Announces Closing of Initial Public Offering206STOCKHOLM, SWEDEN - October 8, 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) ("Karolinska Development" or the "Company") announces that its portfolio company Aprea Therapeutics, Inc. ("Aprea")...
► Artikel lesen
27.09.Karolinska Development AB (publ): Karolinska Development publishes prospectus supplement relating to the directed ...-
23.09.Karolinska Development AB (publ): Karolinska Developments portfolio company Lipidor has been approved for listing on Nasdaq First North Growth Market188STOCKHOLM, SWEDEN - September 23, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company Lipidor AB has been approved for listing on Nasdaq First North Growth Market....
► Artikel lesen
12.09.Karolinska Development AB (publ): Karolinska Development extends the subscription period in the directed share ...-
09.09.Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission150STOCKHOLM - September 9, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has filed a registration statement on September 6, 2019 with the...
► Artikel lesen
30.08.Karolinska Development AB (publ): Interim Report January - June 2019293STOCKHOLM - 30 August 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report for the period January - June 2019. The full report is available on the Company's website. "Karolinska...
► Artikel lesen
29.08.Karolinska Development AB (publ): Karolinska Development extends the subscription period in the directed share ...-
28.08.Karolinska Development AB (publ): Karolinska Development's portfolio company Promimic receives FDA approval for its HAnano Surface on a spinal implant191STOCKHOLM - August 28, 2019. Karolinska Development's portfolio company Promimic today announced that the company's first spinal device utilizing HAnano Surface to improve osseointegration has now been...
► Artikel lesen
20.08.Karolinska Development AB (publ): Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-6219174STOCKHOLM - August 20, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company Forendo Pharma has initiated dosing in a Phase 1b clinical study with the aim...
► Artikel lesen
16.08.Karolinska Development AB (publ): New date for publication of Karolinska Developments Interim Report January - June 2019205STOCKHOLM, SWEDEN - 16 August 2019. Karolinska Development AB ("Karolinska Development" or the "Company") hereby announces that the Company's Q2 report for the period January - June will be published...
► Artikel lesen
09.08.Karolinska Development AB (publ): arolinska Development's portfolio company OssDsign prepares for launch in Japan following regulatory filing92STOCKHOLM - August 9, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign AB has filed for Japanese regulatory approval of OssDsign Cranial and...
► Artikel lesen
05.08.Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics appoints Scott Coiante as CFO47STOCKHOLM - August 5, 2019. Karolinska Development's portfolio company Aprea Therapeutics today announced the appointment of Scott Coiante as Senior Vice President and Chief Financial Officer. An experienced...
► Artikel lesen
02.08.Karolinska Development AB (publ): Karolinska Development extends the subscription period in the directed share ...-
19.07.Karolinska Development AB (publ): Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma32STOCKHOLM - July 19, 2019. Karolinska Development's portfolio company Forendo Pharma announces today that Sunstone Life Science Ventures joins the existing international investor syndicate and has made...
► Artikel lesen
19.07.Karolinska Development AB (publ): Karolinska Development extends the subscription period in the directed share ...-
09.07.Karolinska Development AB (publ): Karolinska Development's portfolio company Dilafor initiates Phase 2b clinical trial with tafoxiparin in women planned for labor induction49STOCKHOLM - July 9, 2019. Karolinska Development's portfolio company Dilafor AB, a drug development company focusing on the development of tafoxiparin for obstetric indications, has enrolled the first...
► Artikel lesen
05.07.Karolinska Development AB (publ): Karolinska Development publishes prospectus relating to the directed share issue-
01.07.Karolinska Development AB (publ): Karolinska Development appoints Fredrik Järrsten as Deputy CEO38STOCKHOLM, SWEDEN - 1 July 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that Fredrik Järrsten has been appointed as Deputy Chief Executive Officer and Chief Financial Officer....
► Artikel lesen
28.06.Karolinska Development AB (publ): Update concerning subscription undertakings in Karolinska Development's directed share issue to the holders of the Company's convertible loan54STOCKHOLM, SWEDEN - 28 June 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) ("Karolinska Development" or the "Company") announced on 29 May 2019 that the Board of Directors of the Company has...
► Artikel lesen
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1